SUBACUTE ATAXIC SENSITIVE SYNDROME
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingSLEEPY PATIENTS WITH MYOTHONIC DYSTROPHY TIPE 1 DO NOT HAVE A DISTINCT NEUROPSYCHOLOGICAL AND NEUROIMAGING PATTERN COMPARED TO NON SLEEPY PATIENTS
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingClinically Meaningful Improvement in Physical Fatigue and Muscle Weakness Fatigability with Rozanolixizumab: Post Hoc Analysis of MG Symptoms PRO Responder Rate in the MycarinG study
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingEvaluation of non-invasive biological sources for assessing methylation levels of FSHD-associated locus
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingNext-generation sequencing for the diagnosis of primary muscle disorder: the experience of the Dino Ferrari Center in Milan.
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingMuscle MRI findings in Italian patients with myofibrillar and distal myopathies: an exploratory analysis from ITA-MeD.
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingNeed for tube feeding in SMA type I patients treated with disease modifying therapies: prognostic factors
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingNovel TMEM43 mutations lead to extreme variability of clinical phenotype
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingRapid regression of bulbar symptoms in myasthenia gravis refractory clinical relapse after eculizumab infusion as rescue therapy
/0 Commenti/in GRUPPO 3, musumeci, nigro, Uncategorized/da expomeetingSEGRETERIA NAZIONALE AIM
Seguici sulle nostre pagine social
SEGRETERIA ORGANIZZATIVA FIRST CLASS
First Class S.r.l. Meetings and Conferences